A retrospective study of patterns of prophylactic corticosteroid use with axicabtagene ciloleucel in patients with relapsed/refractory large B-Cell lymphoma
Latest Information Update: 16 Jan 2023
At a glance
- Drugs Axicabtagene ciloleucel (Primary)
- Indications B-cell lymphoma; Diffuse large B cell lymphoma
- Focus Therapeutic Use
Most Recent Events
- 16 Jan 2023 New trial record
- 13 Dec 2022 Results presented at the 64th American Society of Hematology Annual Meeting and Exposition